N,N'-Dicyclohexyl-4-morpholinecarboxamidine, 98.0%, 10g

6-Methylsalicylic acid ethyl ester, 95.0%, 1g

Methyl 3-(4-Methoxyphenyl)propanoate, 97.0%, 1g

EDTA sale tetrasodico diidrato, minimo 99%, 500 g, confezione in plastica.

3,4-Dihydro-5-hydroxy-1(2H)-isoquinolinone, 95.0%, 5g

5-methyl-1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]methyl}-1H-pyrazol-3-amine, 1g

3-(Chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride, 95.0%, 100g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(((tert-butoxycarbonyl)amino)methyl)phenyl)propanoic acid, 97%, 10g

Hydroquinone>99.0%(T)25g

Tetrahydro-2H-pyran-4-carbohydrazide, 95.0%, 500mg

8-Bromo-[1,2,4]triazolo[1,5-a]pyridin-6-amine, 98%, 1g

Aluminum tert-Butoxide>98.0%(T)5g

Risperidone>98.0%(HPLC)(T)500mg